Abstract
This research service covers the U.S. COPD market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product class: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches. The novel therapeutic approaches segment covers selected products in the pipeline that are outside current marketed segments. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.
Table of Contents
1 EXECUTIVE SUMMARY
- Executive Summary
- Introduction
2 TOTAL MARKET
- Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
- Disease Overview
- Introduction
- Disease Definition
- Symptoms
- Risk Factors
- Diagnosis
- Treatments
- Drug Delivery Methods
- Disease Statistics
- Competitive Structure
- Patient Outlook
- Patient Forecasts
- General Market Trends
- Challenges
- Strategic Recommendations for Challenges
- Market Drivers
- Market Restraints
3 MARKETED THERAPIES OVERVIEW
- Overview
- Bronchodilators
- Anti-inflammatories
- Combination Therapies
- Novel Therapeutic Approaches
4 APPENDIX
- Decision Support Databases
- Chronic Obstructive Pulmonary Disease Population
- Prevalence of Male Smokers
- Prevalence of Female Smokers
- Population 65 and Over
- Prevalence of Asthma
